Benefit-Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study.
Ammar Abdulrahman JairounSabaa Saleh Al-HemyariMoyad ShahwanTariq Al-QirimMonzer ShahwanPublished in: Clinical medicine insights. Endocrinology and diabetes (2024)
Regulatory frameworks must evolve to keep pace with the rapid adoption of AI in healthcare. Sustained attention to ethical considerations, including obtaining patient consent, safeguarding data privacy, ensuring accountability, and promoting fairness, remains critical. Despite its potential impact on the human aspect of healthcare, AI will remain an integral component of patient-centered care. Striking a balance between AI-assisted decision-making and human expertise is essential to uphold trust and provide comprehensive patient care.
Keyphrases
- healthcare
- endothelial cells
- artificial intelligence
- decision making
- risk assessment
- big data
- health information
- type diabetes
- induced pluripotent stem cells
- electronic health record
- pluripotent stem cells
- palliative care
- transcription factor
- working memory
- case report
- adipose tissue
- human health
- quality improvement
- heavy metals
- metabolic syndrome
- deep learning
- weight loss
- climate change
- chronic pain
- health insurance
- quantum dots